DaVita Inc. Files 2025 Proxy Statement
Ticker: DVA · Form: DEF 14A · Filed: Apr 24, 2025 · CIK: 927066
| Field | Detail |
|---|---|
| Company | Davita Inc. (DVA) |
| Form Type | DEF 14A |
| Filed Date | Apr 24, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance
TL;DR
DaVita's proxy statement is out, shareholders check exec pay & board details for 2024.
AI Summary
DaVita Inc. filed its DEF 14A on April 24, 2025, detailing executive compensation and board member information for the fiscal year ending December 31, 2024. Key individuals like Javier J. Rodriguez and Joel Ackerman are listed as members, with compensation details to be further elaborated in the filing. The company, formerly known as Total Renal Care Holdings Inc., is headquartered in Denver, Colorado.
Why It Matters
This filing provides crucial information for shareholders regarding executive compensation, board structure, and corporate governance, influencing investment decisions and company accountability.
Risk Assessment
Risk Level: medium — DEF 14A filings are routine disclosures, but the specifics of executive compensation and corporate governance can reveal underlying risks or strengths.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for compensation and governance details)
- 20250424 — Filing Date (Date the DEF 14A was submitted to the SEC)
Key Players & Entities
- DaVita Inc. (company) — Filer of the DEF 14A
- Javier J. Rodriguez (person) — Member of the Board of Directors
- Joel Ackerman (person) — Member of the Board of Directors
- David P. Maughan (person) — Member of the Board of Directors
- Kathleen A. Waters (person) — Member of the Board of Directors
- Total Renal Care Holdings Inc. (company) — Former name of DaVita Inc.
FAQ
What is the primary purpose of this DEF 14A filing for DaVita Inc.?
The primary purpose is to provide shareholders with information regarding the company's annual meeting, including details on executive compensation, board of directors, and corporate governance matters for the fiscal year ending December 31, 2024.
Who are some of the key individuals mentioned in relation to DaVita Inc.'s board or executive team in this filing?
Key individuals mentioned include Javier J. Rodriguez (PeoMember), Joel Ackerman (NonPeoNeoMember), David P. Maughan (NonPeoNeoMember), and Kathleen A. Waters (NonPeoNeoMember).
What was DaVita Inc. formerly known as?
DaVita Inc. was formerly known as DaVita Healthcare Partners Inc. and prior to that, Total Renal Care Holdings Inc.
When is DaVita Inc.'s fiscal year end?
DaVita Inc.'s fiscal year ends on December 31st.
What is the filing date of this DEF 14A document?
This DEF 14A document was filed on April 24, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 24, 2025 by Javier J. Rodriguez regarding DAVITA INC. (DVA).